MEDPACE

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 2,700 people across 36 countries.

FEATURED PRODUCTS

Hematology And Oncology Hematology And Oncology

Gain a competitive advantage for your study in the ever-evolving landscape of hematology and oncology drug and biologic clinical development.

WEBINARS

  • Infectious Diseases In The Immunocompromised Host – A Dynamic Landscape With Challenges For Clinical Development
    Infectious Diseases In The Immunocompromised Host – A Dynamic Landscape With Challenges For Clinical Development

    In this webinar, medical experts from Medpace’s Infectious Diseases and Hematology/Oncology teams discuss infectious diseases in the immunocompromised host—with a focus on hematologic malignancies and hematopoietic cell transplantation patients—and the unique challenges for clinical development.

  • Oncology Trial Recruitment: Challenging Indications And Challenging Studies
    Oncology Trial Recruitment: Challenging Indications And Challenging Studies

    In this presentation, Medpace medical and operational experts discuss the trial design challenges for specific oncology populations and how to overcome them.

  • Special Considerations For Managing Immuno-oncology Studies
    Special Considerations For Managing Immuno-oncology Studies

    Lyon Gleich MD, and Jennifer L. Cutter PhD, engage in an interactive discussion on the topic of immuno-oncology and the unique challenges and considerations for managing clinical research.

  • What Happens After Your Device Is Approved? Collecting Data In The Real World
    What Happens After Your Device Is Approved? Collecting Data In The Real World

    In this presentation, Medpace Medical Device experts discuss key considerations for generating real-world evidence and how to apply critical insights in order to drive late-stage clinical research.

  • Pharmacoeconomic Assessment Through Market Approval And Beyond: Theory And Operations
    Pharmacoeconomic Assessment Through Market Approval And Beyond: Theory And Operations

    Pharmacoeconomic assessment of a drug, medical device, or other healthcare product can take on many forms and occur at multiple points in the development cycle. Cost-effectiveness analysis, a major component of pharmacoeconomic assessment, has traditionally occurred in the later phases of product development—either as a piggy-back to a phase III or pivotal clinical trial, or peri-authorization. Join Medpace experts as they explore the application of pharmacoeconomic assessment throughout all phases of clinical trials as well as in observational studies, including registries and other post-marketing data collection.

  • Planning And Executing A Clinical Study For An Orphan Indication
    Planning And Executing A Clinical Study For An Orphan Indication

    Planning and executing a clinical study for an orphan indication presents a unique set of challenges and considerations. In this webinar, Michelle Petersen, Medpace Clinical Trial Manager discusses successful strategies and best practices for addressing some of these including: unique methods to site selection and feasibility, successful recruitment/retention approaches, overview of common study execution needs, and optimal training and monitoring strategies.

  • Precision Medicine: Opportunities And Challenges For Clinical Trials
    Precision Medicine: Opportunities And Challenges For Clinical Trials

    The momentum and muscle behind "finding the right drug for the right patient at the right dose" has further escalated with President Barack Obama’s announcement of a $215 million dollar Precision Medicine Initiative. In this webinar, Dr. Frank Smith will explore advances in precision medicine and how it is affecting clinical research. As a pediatric hematologist/oncologist, he will use his extensive clinical and research background as a backdrop for the discussion.

  • Rare Disease Disorders And CNS Drug Development – Paving The Way For Precision Medicine
    Rare Disease Disorders And CNS Drug Development – Paving The Way For Precision Medicine

    In CNS drug development, more and more diseases once viewed as common are now known to be collections of rare variants. Our deepening understanding of the human genome and pathophysiology has led to fragmented classifications of common neurological or psychiatric disorders based on identified genetic markers. 

  • Getting Treatment Options To Rare Disease Patients Faster: Putting Patients First In Clinical Trials
    Getting Treatment Options To Rare Disease Patients Faster: Putting Patients First In Clinical Trials

    In this webinar, Medpace discusses how patient-focused clinical trial design and collaborative approaches to site enrollment can accelerate clinical research. This presentation features a doctor from Cincinnati Children's Hospital Medical Center and a parent of a child with Duchenne muscular dystrophy.

  • Navigating The Complexities Of NASH Development: Valuable Insights From A Key Opinion Leader
    Navigating The Complexities Of NASH Development: Valuable Insights From A Key Opinion Leader

    In this webinar, medical and operations experts from Medpace facilitate a Q&A session with Dr. Stephen A. Harrison, an experienced Key Opinion Leader (KOL) in NASH. The presenters participate in an in-depth discussion on selected topics associated with NASH development as well as strategies and opportunities for researchers.

  • Opportunities And Challenges In Microbiome-based Clinical Research
    Opportunities And Challenges In Microbiome-based Clinical Research

    In this webinar, experts from Medpace and Diversigen engage in an interactive discussion on the possibilities as well as the challenges in clinical research and development involving the human microbiome.

  • Latin America: Challenges & Opportunities In Clinical Research
    Latin America: Challenges & Opportunities In Clinical Research

    With an established regulatory environment and a strong healthcare infrastructure, Latin America continues to grow as an advantageous landscape for conducting clinical research. Join Medpace experts Anibal Calmaggi, MD, Senior Medical Director, Infectious Diseases and Vaccines, and Wanda Dobrzanski, MD, Director Clinical Operations, Pediatric infectious diseases and Pharmaceutical medicine specialist, as they share their collective 36 years of experience in designing and managing clinical research in Latin America.

  • Drivers And Trends In Cardiovascular Device Development: Insights From Key Opinion Leaders
    Drivers And Trends In Cardiovascular Device Development: Insights From Key Opinion Leaders

    New trends are emerging in medical device development. In this webinar, Dr. Dean J. Kereiakes, a leading Key Opinion Leader in interventional cardiology, shares his expert views on how the cardiovascular medical device world is evolving, and how this field links to daily clinical practice and research. Through panel discussion with Dr. Nicholas Alp and Danny Detiege and through audience interaction, he provides valuable insights into the future of medical device clinical development.

  • Beware The Hidden Costs Of Conducting Clinical Trials: Understanding The Landmines And How To Avoid Them
    Beware The Hidden Costs Of Conducting Clinical Trials: Understanding The Landmines And How To Avoid Them

    In this webinar, we explore four areas that can dramatically affect the cost and timelines of your clinical program and offer insight into elimination and control of these hidden landmines.

  • Gene Editing – Challenges And Future Of CRISPR In Clinical Development
    Gene Editing – Challenges And Future Of CRISPR In Clinical Development

    Gene editing technology is a rapidly evolving area of clinical and translational research that combines the potential of great advances with profound ethical challenges. Join Medpace medical and regulatory experts to discuss the unique opportunity of this evolving technology as it applies to human diseases.

More Webinars

CONTACT INFORMATION

Medpace

5375 Medpace Way

Cincinnati, OH 45227

UNITED STATES

Phone: 513-579-9911

FEATURED ARTICLES